Latest papers

[Idiopatic parafoveolar telangiectasia associated with pseudoviteliform lesion, basal laminar drusen and optic nerve head drusen].

Cutaneous collagenous vasculopathy: ultrastructural and immunohistochemical study of a new case.

Intraoral telangiectasias associated with Raynaud disease: a report of two cases.

Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children.

Resolution of macular edema in Coats' disease with intravitreal bevacizumab.

Unknown: A woman with an erythematous nodule on the scalp.

Analysis of candidate genes for macular telangiectasia type 2.

Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A.

Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A.

The pulsed-dye laser for treatment of cutaneous conditions.

Multiple melanoma arising on a burn scar and extensive sunburn: a case report and a review of the literature

Diagnosis of small bowel telangiectasia in Turner's syndrome using capsule endoscopy.

Prevalence of primary chronic venous disease: the Bulgarian experience.

Can cutaneous telangiectasiae as late normal-tissue injury predict cardiovascular disease in women receiving radiotherapy for breast cancer?

Standard management options for rosacea, part 2: options according to subtype.

A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.

Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2

Cutis marmorata telangiectatica congenita: a prospective study of 27 cases and review of the literature with proposal of diagnostic criteria.

Efficacy of argon plasma coagulation in gastric vascular ectasia in patients with liver cirrhosis.

Vascular-specific laser wavelength for the treatment of facial telangiectasias.